Osteoporosis & Metabolic Bone

May 9, 2023/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Vitamin D: A Metabolic Bone Disease Perspective

The many factors that influence 25(OH)D levels add complexity to questions about hypovitaminosis D

November 1, 2021/Pulmonary

Lung Transplantation and Metabolic Bone Disease

Advancing our knowledge of risk factors

$ual energy x-ray absorptiometry scan showing periosteal elevation, an early diagnostic sign of atypical femoral fractures$

April 19, 2021/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Bisphosphonates and Atypical Femur Fractures in Osteoporosis

Benefit/AFF risk ratio favors 3–5 years of treatment

February 15, 2021/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Late, Severe Effects of Hypophosphatasia

A case study from Chad Deal, MD, illustrates how patients may present

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-RHE-2006261-Deal_Keller_Erdheim-ChesterDisease-CQD-650×450

November 11, 2020/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Paget Disease in a 36-Year-Old Patient?

Puzzling constellation of findings lead to CT-guided bone biopsy

17-RHE-1177 Deal_ConsultQD_Hero Image_650x450pxl

September 2, 2020/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Rapid Bone Loss and Multiple Vertebral Fractures After Denosumab Cessation

If denosumab is stopped, it should be replaced with another osteoporosis treatment

November 7, 2019/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Romosozumab: A New Era in Osteoporosis Treatment

Dual-acting drug increases bone formation while decreasing resorption

March 21, 2019/Geriatrics

Multiple Fractures, Low ALP and High B6 in an Elderly Patient

Diagnosing an inherited metabolic bone disease later in life